GET THE APP

Journal of Bone Research

Journal of Bone Research
Open Access

ISSN: 2572-4916

+44 1478 350008

Commentary - (2023)Volume 11, Issue 3

Bone Marrow and Osteopenia: Understanding the Relationship

Gerhard Carl Hildebrandt*
 
*Correspondence: Gerhard Carl Hildebrandt, Department of Hematology, Markey Cancer Center, University of Kentucky, Lexington, USA, Email:

Author info »

Description

Osteopenia is a condition characterized by low bone density, which puts individuals at a higher risk for fractures. It is a precursor to osteoporosis, a condition in which bone density is significantly decreased, leading to brittle and fragile bones. In recent years, researchers have found a strong link between bone marrow and osteopenia.

Bone marrow is a soft, spongy tissue found inside bones, including the pelvis, sternum, and long bones of the arms and legs. It is responsible for producing various types of blood cells, including red blood cells, white blood cells, and platelets. The production of these cells is crucial for maintaining overall health and immunity.

Bone marrow and osteopenia

Studies have shown that bone marrow plays a critical role in the development and maintenance of healthy bones. As we age, the amount of bone marrow in our bones decreases, which can contribute to the development of osteopenia.

One study found that individuals with lower bone marrow fat content had higher bone density than those with higher bone marrow fat content. This suggests that bone marrow fat may play a role in the development of osteopenia and osteoporosis.

Additionally, bone marrow cells called Mesenchymal Stem Cells (MSCs) are responsible for bone formation and repair. As we age, the number and function of these cells decrease, leading to a decrease in bone density.

Treatment options

There are several treatment options available for osteopenia, including medications, lifestyle changes, and supplements.

Medications: Several medications are available that can help increase bone density and reduce the risk of fractures. These medications include bisphosphonates, hormone therapy, and Selective Estrogen Receptor Modulators (SERMs).

Lifestyle changes: Making certain lifestyle changes can help improve bone health and reduce the risk of osteopenia. These changes include regular exercise, maintaining a healthy diet rich in calcium and vitamin D, quitting smoking, and reducing alcohol consumption.

Supplements: Calcium and vitamin D supplements can also help improve bone health and reduce the risk of osteopenia. It is important to talk to a healthcare provider before starting any supplements.

Prevention

Preventing osteopenia is crucial in reducing the risk of developing osteoporosis. There are several steps individuals can take to prevent osteopenia, including:

• Eating a balanced diet rich in calcium and vitamin D

• Engaging in regular physical activity

• Quitting smoking

• Reducing alcohol consumption

• Getting regular bone density screenings, especially for those at higher risk of developing osteopenia or osteoporosis, such as women over the age of 65, individuals with a family history of osteoporosis, and those with certain medical conditions.

The relationship between bone marrow and osteopenia is complex, with multiple factors contributing to the development and progression of this condition. As we age, the amount and function of bone marrow cells decrease, leading to a decrease in bone density. However, there are several treatment options available that can help improve bone health and reduce the risk of osteopenia and osteoporosis. Making certain lifestyle changes and engaging in regular bone density screenings can also help prevent osteopenia and reduce the risk of fractures.

Author Info

Gerhard Carl Hildebrandt*
 
Department of Hematology, Markey Cancer Center, University of Kentucky, Lexington, USA
 

Citation: Hildebrandt GC (2023) Bone Marrow and Osteopenia: Understanding the Relationship. J Bone Res. 11:228.

Received: 27-Feb-2023, Manuscript No. BMRJ-23-22690; Editor assigned: 01-Mar-2023, Pre QC No. BMRJ-23-22690 (PQ); Reviewed: 15-Mar-2023, QC No. BMRJ-23-22690; Revised: 22-Mar-2023, Manuscript No. BMRJ-23-22690 (R); Published: 29-Mar-2023 , DOI: 10.35248/2572-4916.23.11.228

Copyright: © 2023 Hildebrandt GC. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top